The 3rd Theranostics World Congress featured a patient education day on Saturday, March 14, made possible with support from the Carcinoid Cancer Foundation and the Caring for Carcinoid Foundation. The NorCal CarciNET Community provided funding to record the entire Congress and with their generous permission we share the videos from the patient education day. The Congress was co-sponsored by the Society of Nuclear Medicine and Molecular Imaging and Johns Hopkins Medicine. Click on the video titles or the images to watch the videos. Some of the presentations were not recorded. For the complete program, click here: https://vimeo.com/norcalcarcinet.
State-of-the-Art Management of NETs: Clinician and Patient Perspectives
The Clinician’s Perspective, Thomas O’Dorisio, MD
The Patient’s Perspective, Josh Mailman
Single-center Experience Over More Than a Decade Analyzing 1000 Neuroendocrine Neoplasm Patients Treated with Single- or Duo-Radionuclide Peptide Receptor Radionuclide Therapy, Harshad Kulkani, MD
68Ga-DOTA-Octreotate PET/CT and Outcomes of Peptide Receptor Radionuclide Therapy for Paediatric Patients with Refractory Metastatic Neuroblastoma, Michael Hofman, MD
Gallium Approval in the US: Background and Moving Forward
The US Experience with Imaging and Therapy, Ebrahim Delpassand, MD
The US Experience — Iowa, Yusuf Menda, MD
The US Experience — Vanderbilt, Ron Walker, MD
Pathway to Approval: FDA Perspective, Dwaine Rieves, MD
SNMMI Gallium Users Group: Moving Approval Forward in the US, Michael Graham, MD
Panel Discussion: Gallium Approval in the US, Drs. Richard Baum, Ebrahim Delpassand, Michael Graham, Yusuf Menda, Dwaine Rieves, Ronald Walker
How to Deliver Theranostics
PRRT and Theranostics in Children, Sue O’Dorisio, MD
PRRT + Chemotherapy = Peptide Receptor Chemoradionuclide Therapy (PRCRT), Michael Hofman, MD
Congress Highlights and Looking to the Future: Richard Baum, MD & Frank Roesch, MD
Congratulations to Josh Mailman upon receiving the Service Recognition Award!!
Patient Session with Dr. Richard Baum, Dr. Eric Liu, Dr. Thomas O’Dorisio, and Dr. Edward Wolin, Moderated by Josh Mailman
